Predictors of Mortality in Tocilizumab-Treated Severe COVID-19.

Konstantinos PagkratisSerafeim ChrysikosEmmanouil AntonakisAggeliki PandiChrysavgi Nikolaou KostiEleftherios MarkatisGeorgios HillasAntonia DigalakiSofia KoukidouEleftheria ChainiAndreas AfthinosKaterina DimakouIlias C Papanikolaou

Published in: Vaccines (2022)

Older age and high serum LDH levels are predictors of mortality in tocilizumab-treated severe COVID-19 patients. Hypoxia levels, LDH, and central pulmonary involvement radiologically are associated with intubation and NIV.

Keyphrases

sars cov
rheumatoid arthritis
cardiovascular events
juvenile idiopathic arthritis
coronavirus disease
early onset
rheumatoid arthritis patients
pulmonary hypertension
cardiac arrest
physical activity
endothelial cells
type diabetes
newly diagnosed
disease activity